Meet Our Executive Team
On a mission to drive positive change in the Pharmacovigilance industry.
Adam Sherlock
Chief Executive Officer
Adam is an experienced CEO and pharmacovigilance leader. He brings more than 35 years’ experience of critical safety service and technology solution provision to biopharma R&D, Commercial and Operations functions. Across an impressive career to date, he has held senior roles at Rephine, Kinapse, ProductLife Group and CSC. He is known for his innovative vision, forward-thinking corporate strategy, and proactive and enthusiastic leadership.
John Cogan
Chief Operating Officer
John is an industry veteran with over 30 years’ experience in R&D transformation, champions operational excellence, fosters innovation, and delivers solutions that help organisations flourish in an ever-evolving life sciences landscape.
Kevin John Budge
Chief Financial Officer
Kevin is an accomplished FCA with proven success in private equity-backed ventures, combining robust financial management, strategic reviews, corporate finance, and change management to elevate client value and drive growth.
Arthur Shih
General Counsel
Arthur is General Counsel and an Executive Leadership Team member with extensive international legal and commercial experience built over 25 years in private practice and in-house leadership roles.
Build Your Career with Qinecsa
At Qinecsa we understand the impact of the important work we do. We provide the right tools to empower our people and our passion towards drug safety makes us a unique group of talented people with common goal.
